First MenB vaccine protects against the most common cause of meningococcal disease in Canada
(NC) Parents understand the importance of wearing a seatbelt, helmet and sunscreen to protect their families. But we often forget about the importance of immunization to help keep our family healthy and avoid illness.
“Vaccines continue to be underused and undervalued despite being the most effective protection from devastating diseases,” said Dr. Ron Gold, Senior Medical Advisor, Member of the Board of Directors of the Meningitis Research Foundation of Canada. “Vaccines have played a significant role in helping to reduce and eradicate disease, particularly among children. I encourage parents to talk to their doctor about vaccines that will help protect their families.”
In Canada, MenB infection is the leading cause of meningococcal meningitis particularly in infants. Bexsero, a vaccine to help protect infants, children and adolescents against Men B is now available in Canada. Up until now vaccines were available to help protect only against A, C, W and Y strains.
Protect your family and talk to your doctor about immunization against vaccine-preventable diseases.
* Meningococcal disease is a sudden, aggressive illness with greatest risks amongst infants, toddlers and adolescents. Meningococcal serogroup B, known as MenB, is one of five main types of meningococcal bacteria (A, B, C, W and Y).
Word count: 278
Articles are provided free of charge. Articles appearing on web sites, must credit www.newscanada.com. Articles appearing in Print, must credit News Canada with (NC) at beginning of an article or – News Canada at the end. Any source/sponsor of the information quoted in the text must also be identified as presented. Images are only to be used with corresponding editorial copy. Usage of News Canada articles constitutes your acceptance of these terms and an agreement between you and News Canada.